Lipoprotein
mimetic nanostructures, which consist of an amphiphilic
lipid shell, a hydrophobic core, and an apolipoprotein mimetic peptide,
serve as a versatile platform for the design of drug delivery vehicles
as well as the investigation of supramolecular assemblies. Porphyrin
incorporation into biomimetic lipoproteins allows one to take advantage
of the inherent multimodal photophysical properties of porphyrins,
yielding various fluorescence, photoacoustic, and photodynamic agents.
To facilitate their incorporation into a lipoprotein structure, porphyrins
have been conjugated through a variety of strategies. However, the
effects of the conjugate structure on the associated nanoparticle’s
phototherapeutic properties warrants further investigation. Herein,
we systematically investigated the effects of two widely utilized
porphyrin conjugates, oleylamide and lipid, on biophotonic properties
of their resultant porphyrin-lipoprotein nanoparticles in
vitro and in vivo. Specifically, we demonstrated
that incorporation of the porphyrin moiety as an oleylamide conjugate
leads to a highly stable J-aggregate with strong photoacoustic contrast,
while incorporation as an ampiphilic lipid moiety into the lipid shell
yields an effective fluorescent and photodynamic agent. The current
study proposes a rational design strategy for next-generation lipoprotein-based
phototheranostic agents, for which nanoassembly-driven biophotonic
and therapeutic properties can be tailored through the specific selection
of porphyrin conjugate structures.